Sir,

A dome-shaped macula (DSM) is an inward protrusion of the macula seen on optical coherence tomography (OCT) in highly myopic eyes, which was first described in 2008 by Gaucher et al.1 Since DSM appears to be a distinct feature of highly myopic eyes,2, 3 it could be suspected that choroidal neovascularization (CNV) that develops in myopic eyes with DSM may have different clinical features and may follow a course different from that of CNV found in myopic eyes without DSM. However, studies on the therapeutic outcome of CNV associated with DSM are limited. When searching PubMed using the keyword ‘dome-shaped macula’, only one brief report that showed the visual outcome of myopic CNV with DSM after 1-year intravitreal ranibizumab treatment was identified.3 The purpose of this study was to determine the 2-year visual and anatomical outcomes of intravitreal bevacizumab (IVB) treatment for myopic CNV with DSM features. The secondary objective was to compare patients with and without DSM, to investigate whether there was any difference in the clinical features and therapeutic outcome in these two groups after IVB treatment.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD